MicroRNA Isoforms Contribution to Melanoma Pathogenesis.
TCGA
isomiR
melanoma
next generation sequencing
Journal
Non-coding RNA
ISSN: 2311-553X
Titre abrégé: Noncoding RNA
Pays: Switzerland
ID NLM: 101652294
Informations de publication
Date de publication:
27 Sep 2021
27 Sep 2021
Historique:
received:
12
07
2021
revised:
15
09
2021
accepted:
21
09
2021
entrez:
26
10
2021
pubmed:
27
10
2021
medline:
27
10
2021
Statut:
epublish
Résumé
Cutaneous melanoma (CM) is the most lethal tumor among skin cancers, and its incidence is constantly increasing. A deeper understanding of the molecular processes guiding melanoma pathogenesis could improve diagnosis, treatment and prognosis. MicroRNAs play a key role in melanoma biology. Recently, next generation sequencing (NGS) experiments, designed to assess small-RNA expression, revealed the existence of microRNA variants with different length and sequence. These microRNA isoforms are known as isomiRs and provide an additional layer to the complex non-coding RNA world. Here, we collected data from NGS experiments to provide a comprehensive characterization of miRNA and isomiR dysregulation in benign nevi (BN) and early-stage melanomas. We observed that melanoma and BN express different and specific isomiRs and have a different isomiR abundance distribution. Moreover, isomiRs from the same microRNA can have opposite expression trends between groups. Using The Cancer Genome Atlas (TCGA) dataset of skin cancers, we analyzed isomiR expression in primary melanoma and melanoma metastasis and tested their association with NF1, BRAF and NRAS mutations. IsomiRs differentially expressed were identified and catalogued with reference to the canonical form. The reported non-random dysregulation of specific isomiRs contributes to the understanding of the complex melanoma pathogenesis and serves as the basis for further functional studies.
Identifiants
pubmed: 34698264
pii: ncrna7040063
doi: 10.3390/ncrna7040063
pmc: PMC8544706
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
PLoS One. 2013 Jan 22;8(1):
pubmed: 29364961
RNA. 2012 Feb;18(2):177-92
pubmed: 22190743
Nucleic Acids Res. 2015 Jul 13;43(12):e77
pubmed: 25779041
Bioinformatics. 2021 Jan 20;:
pubmed: 33471076
Cancer. 2018 Sep 1;124(17):3490-3499
pubmed: 29663336
Genome Res. 2010 Oct;20(10):1398-410
pubmed: 20719920
Adv Biomed Res. 2018 Nov 27;7:143
pubmed: 30596053
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
Genome Biol. 2011 Dec 30;12(12):R126
pubmed: 22208850
Cells. 2019 Dec 25;9(1):
pubmed: 31881725
J Invest Dermatol. 2009 Jul;129(7):1740-51
pubmed: 19212343
J Recept Signal Transduct Res. 2021 Apr;41(2):180-187
pubmed: 32772782
Cell Physiol Biochem. 2018;50(1):385-397
pubmed: 30286469
Genes Dev. 2010 May 15;24(10):992-1009
pubmed: 20413612
Endocr Relat Cancer. 2017 Oct;24(10):543-553
pubmed: 28830935
Essays Biochem. 2021 Oct 27;65(4):641-655
pubmed: 34414406
J Cell Sci. 2007 Jun 1;120(Pt 11):1833-40
pubmed: 17515481
J Surg Res. 2016 Jun 15;203(2):434-40
pubmed: 27363653
Oncol Lett. 2021 May;21(5):370
pubmed: 33747226
Sci Rep. 2015 Feb 03;5:8201
pubmed: 25643913
Cancer Cell. 2011 Jul 12;20(1):104-18
pubmed: 21741600
Biochem Biophys Res Commun. 2015 Jan 2;456(1):361-6
pubmed: 25475727
Lancet Oncol. 2014 Aug;15(9):e371-81
pubmed: 25079100
Nat Rev Mol Cell Biol. 2005 May;6(5):376-85
pubmed: 15852042
JCI Insight. 2019 Mar 21;4(6):
pubmed: 30895946
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4275-4284
pubmed: 31173299
BMC Bioinformatics. 2021 Apr 26;22(1):215
pubmed: 33902448
Mol Med Rep. 2018 Aug;18(2):2492-2498
pubmed: 29901141
Int J Mol Sci. 2020 Jun 26;21(12):
pubmed: 32604720
Mol Oncol. 2019 Jan;13(1):74-98
pubmed: 30499222
Cancer Res. 2008 Apr 15;68(8):2745-54
pubmed: 18417445
BMC Genomics. 2018 May 25;19(1):401
pubmed: 29801434
Oncogene. 2013 Apr 11;32(15):1959-70
pubmed: 22751131
Nature. 2002 Jun 27;417(6892):949-54
pubmed: 12068308
Oncotarget. 2014 Sep 30;5(18):8790-802
pubmed: 25229428
J Med Genet. 2016 Jan;53(1):1-14
pubmed: 26337759
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
N Engl J Med. 2015 Nov 12;373(20):1926-36
pubmed: 26559571
Nucleic Acids Res. 2017 Apr 7;45(6):2973-2985
pubmed: 28206648
Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):E1106-15
pubmed: 25713380
Cell Death Dis. 2021 May 12;12(5):473
pubmed: 33980826
Proc Natl Acad Sci U S A. 2017 Jul 18;114(29):E5930-E5939
pubmed: 28684402
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
IUBMB Life. 2020 Sep;72(9):2034-2044
pubmed: 32687246
In Vivo. 2014 May-Jun;28(3):273-85
pubmed: 24815827
Cancer Lett. 2013 Dec 1;341(2):240-7
pubmed: 23962556
Cell Biosci. 2021 Feb 25;11(1):43
pubmed: 33632341
J Cell Biochem. 2019 Aug;120(8):13262-13274
pubmed: 30994959
J Invest Dermatol. 2018 Apr;138(4):882-892
pubmed: 29104160
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D140-4
pubmed: 16381832
Oncol Res. 2018 Oct 17;26(9):1447-1455
pubmed: 29495972
Cancer Res. 2018 Mar 1;78(5):1140-1154
pubmed: 29229607
Nature. 2017 May 11;545(7653):175-180
pubmed: 28467829
J Am Acad Dermatol. 2017 Nov;77(5):893-901
pubmed: 28818438
J Biol Chem. 2012 Apr 6;287(15):11769-77
pubmed: 22354972
Ann Surg Oncol. 2018 Aug;25(8):2105-2110
pubmed: 29850954
Cancer Discov. 2013 Mar;3(3):338-49
pubmed: 23171796
J Am Acad Dermatol. 2004 Nov;51(5):803-8
pubmed: 15523363